Troglitazone increases IL-1β induced cyclooxygenase-2 and inducible nitric oxide synthase expression via enhanced phosphorylation of IκBα in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 10, 2008, Pages 1955-1958

  Kang, Young Jin ^a   Kim, Hee Sun ^a   Choi, Hyoung Chul ^a  

^a Yeungnam University   (South Korea)

Author keywords

Cyclooxygenase 2; Inducible nitric oxide synthase; Spontaneously hypertensive rat; Troglitazone; Wistar Kyoto rat

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CIGLITAZONE; CYCLOOXYGENASE 2; I KAPPA B ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; TROGLITAZONE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; DRUG EFFECT; ENZYME INDUCTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

ANIMALS; BLOTTING, WESTERN; CHROMANS; CYCLOOXYGENASE 2; HYPOGLYCEMIC AGENTS; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; MALE; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLIDINEDIONES;

EID: 53549099152     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1955     Document Type: Article

References (26)

1. Fajas L., Debril M. B., Auwerx J., J. Mol Endocrinol., 27, 1-9 (2001).
2. Saltiel A. R., Olefsky J. M., Diabetes, 45, 1661-1669 (1996).
3. Ahmed W., Ziouzenkova O., Brown J., Devchand P., Francis S., Kadakia M., Kanda T., Orasanu G., Sharlach M., Zandbergen F., Plutzky J., J. Intern. Med., 262, 184-198 (2007).
4. Pittas A. G., Greenberg A. S., Expert. Opin. Pharmacother., 3, 529-540 (2002).
5. Hong K. M., Belperio J. A., Keane M. P., Burdick M. D., Strieter R. M., J. Biol. Chem., 282, 22910-22920 (2007).
6. Duan S. Z., Usher M. G., Mortensen R. M., Circ. Res., 102, 283-294 (2008).
7. Quinn C. E., Hamilton P. K., Lockhart C. J., McVeigh G. E., Br. J. Pharmacol, 153, 636-645 (2008).
8. Staels B., Fruchart J. C., Diabetes, 54, 2460-2470 (2005).
9. Hyong A., Jadhav V., Lee S., Tong W., Rowe J., Zhang J. H., Tang J., Brain Res., 1215, 218-224 (2008).
10. Haraguchi G., Kosuge H., Maejima Y., Suzuki J., Imai T., Yoshida M., Isobe M., Intensive Care Med., 34, 1304-1312 (2008).
11. Guo L., Zhang L., Sun Y., Muskhelishvili L., Blann E., Dial S., Shi L., Schroth G., Dragan Y P., Mol. Diversity, 10, 349-360 (2006).
12. Park Y M., Won J. H., Yun K. J., Ryu J. H., Han Y N., Choi S. K., Lee K. T., Biol. Pharm. Bull., 29, 985-990 (2006).
13. Choi H. C., Lee S. G., Kim J. H., Kim J. Y., Sohn U. D., Ha J. H., Lee K. Y., Kim W. J., Kor. J. Physiol Pharmacol., 5, 343-351 (2001).
14. Kim H. J., Tsoyi K., Heo J. M., Kang Y J., Park M. K., Lee Y. S., Lee J. H., Seo H. G., Yun-Choi H. S., Chang K. C., J. Pharmacol Exp. Ther., 320, 782-789 (2007).
15. Kim J. Y., Kim T. H., Kim S. S., Biochem. Biophys. Res. Commun., 368, 779-785 (2008).
16. Cuzzocrea S., Pisano B., Dugo L., Ianaro A., Maffia P., Patel N. S. A., Di Paola R., Ialenti A., Genovese T., Chatterjee P. K., Di Rosa M., Caputi A. P., Thiemermann C., Mm J. Pharmacol., 483, 79-93 (2004).
17. Abdelrahman M., Sivarajah A., Thiemermann C., Cardiovasc. Res., 65, 772-781 (2005).
18. Sabichi A. L., Subbarayan V., Llansa N., Lippman S. M., Menter D. G., Cancer Epidemiol Biomarkers. Prev., 13, 1704-1709 (2004).
19. Pontsler A. V., St. Hilaire A., Marathe G. K., Zimmerman G. A., Mclntyre T. M., J. Biol. Chem., 277, 13029-13036 (2002).
20. Resink T. J., Scott-Burden T., Bauer U., Buhler F. R., J. Hypertens., 5, S145-S148(1987).
21. Kim H. Y., Kang Y J., Song I. H., Choi H. C., Kim H. S., Hypertens. Res., 31, 515-523(2008).
22. Vansant G., Pezzoli P., Saiz R., Brich A., Duffy C., Ferre F., Monforte J., Int. J. Toxicol., 25, 85-94 (2006).
23. Reddy S. T., Wadleigh D. J., Herschman H. R., J. Biol Chem., 275, 3107-3113(2000).
24. Feinstein D. L., Spagnolo A., Akar C., Weinberg G., Murphy P., Gavrilyuk V., Dello Russo C., Biochem. Pharmacol., 70, 177-178 (2005).
25. Ogawa D., Nomiyama T., Nakamachi T., Heywood E. B., Stone J. F., Berger J. P., Law R. E., Bruemmer D., Circ. Res., 98, e50-e59 (2006).
26. Fukuda N., Hu W. Y., Teng H., Chikara S., Nakayama M., Kishioka H., Kanmatsuse K., Atherosclerosis, 163, 229-239 (2002).